Shopping Cart
- Remove All
Your shopping cart is currently empty
Tepotinib hydrochloride(1 : x)
🥰Excellent
Catalog No. T9601Cas No. 1103508-80-0
Tepotinib hydrochloride(1 : x) is an orally bioavailable, mesenchymal-epithelial transition (MET) TKI developed mainly for selected NSCLC patients with METex14 skipping mutations.
Tepotinib hydrochloride(1 : x)
🥰Excellent
Purity: 99.81%
Catalog No. T9601Cas No. 1103508-80-0
Tepotinib hydrochloride(1 : x) is an orally bioavailable, mesenchymal-epithelial transition (MET) TKI developed mainly for selected NSCLC patients with METex14 skipping mutations.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | 140 € | In Stock | |
| 5 mg | 319 € | In Stock | |
| 10 mg | 472 € | In Stock | |
| 25 mg | 753 € | In Stock | |
| 50 mg | 1.073 € | In Stock | |
| 1 mL x 10 mM (in DMSO) | 401 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Tepotinib hydrochloride(1 : x)"
L-Ascorbic acid 2-phosphate trisodium
Sodium L-ascorbyl-2-phosphate, Sodium ascorbyl phosphate, Sodium ascorbyl monophosphate, L-Ascorbic acid 2-phosphate trisodium salt, 2-Phospho-L-ascorbic acid trisodium salt
T218566170-10-3
L-Ascorbic acid 2-phosphate trisodium (Sodium ascorbyl phosphate) is utilized in biocatalytic dephosphorylation for electric power generation and electrochemical detection assays.
- 39 €
Size
QTY
Cinchonine
Cited
LA40221, (8R,9S)-Cinchonine
T0012118-10-5
Cinchonine (LA40221), a local anesthetic of the amide type, now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local narcotics and its parenteral use is restricted to spinal anesthesia.
- 41 €
Size
QTY
CitedVismodegib Cited
RG 3616, GDC-0449, Erivedge
T2590879085-55-9
Vismodegib (GDC-0449) is a hedgehog pathway inhibitor (IC50: 3 nM). It also inhibits P-gp (IC50: 3.0 μM), ABCG2 (IC50: 1.4 μM).
- 36 €
Size
QTY
CitedPolyoxyethylene stearate
POES
T165619004-99-3
Polyoxyethylene stearate (POES) is an agent of non-ionic emulsifying.
- 42 €
Size
QTY
Chlorpropamide
Diabinese
T049094-20-2
Chlorpropamide (Diabinese) is a sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification.
- 29 €
Size
QTY
Probucol
DH-581
T025423288-49-5
Probucol (DH-581), an anti-hyperlipidemic drug, can lower the level of cholesterol in the bloodstream by increasing the LDL catabolic rate.
- 55 €
Size
QTY
Acridone
T20003578-95-0
Acridone could induce cell apoptosis, inhibited ABCG2 (ATP-binding cassette sub-family G member 2) protein, and adjusted hormone level.
- 28 €
Size
QTY
Glibenclamide Cited
Glyburide
T163410238-21-8
Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
- 42 €
Size
QTY
CitedVigabatrin
Vigabatrine, Sabril
T012860643-86-9
Vigabatrin (Sabril), an analogue of gamma-aminobutyric acid, is an irreversible inhibitor of 4-aminobutyrate Transaminase responsible for the catabolism of γ-aminobutyric acid.
- 41 €
Size
QTY
Encequidar mesylate
HM30181A mesylate, HM30181 mesylate
T11578L849675-87-2
Encequidar mesylate (HM30181A mesylate) is a competitive P-glycoprotein inhibitor.
- 33 €
Size
QTY
Atazanavir sulfate
BMS-232632 sulfate
T0100229975-97-7
Atazanavir sulfate (BMS-232632 sulfate) is an azapeptide and HIV-protease inhibitor used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents.
- 37 €
Size
QTY
Atazanavir Cited
Zrivada, Reyataz, Latazanavir, BMS-232632
T0100L198904-31-3
Atazanavir (BMS-232632)(BMS-232632) is an highly effective HIV-1 protease inhibitor.
- 37 €
Size
QTY
CitedSelect Batch
Purity:99.81%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Tepotinib hydrochloride(1 : x) is an orally bioavailable, mesenchymal-epithelial transition (MET) TKI developed mainly for selected NSCLC patients with METex14 skipping mutations. |
| In vitro | Tepotinib hydrochloride(1 : x) potently inhibits ABCB1 and ABCG2 efflux transporters, which was confirmed by molecular docking. In addition, Tepotinib hydrochloride(1 : x) inhibited several recombinant cytochrome P450 (CYP) isoforms with varying potency. Tepotinib hydrochloride(1 : x) synergistically reversed daunorubicin and mitoxantrone resistance in cells with ABCB1 and ABCG2 overexpression, respectively[2]. |
| Molecular Weight | 529.04 |
| Formula | C29H29ClN6O2 |
| Cas No. | 1103508-80-0 |
| Smiles | Cl.CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (94.51 mM)  | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Tepotinib hydrochloride(1 : x) | purchase Tepotinib hydrochloride(1 : x) | Tepotinib hydrochloride(1 : x) cost | order Tepotinib hydrochloride(1 : x) | Tepotinib hydrochloride(1 : x) chemical structure | Tepotinib hydrochloride(1 : x) in vitro | Tepotinib hydrochloride(1 : x) formula | Tepotinib hydrochloride(1 : x) molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.